Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|July 5, 2018
Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation TherapyNicholas J Giacalone, Nastaran Milani, Bhupendra Rawal, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patientsVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 8, 2021
Imaging features, therapies, and outcomes of fibrosing inflammatory pseudotumor of the nasopharynx: A systematic reviewShruti Mishra, Chong Hyun Suh, Regan W Bergmark, et al.
Journal for Immunotherapy of Cancer|December 18, 2015
Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and reviewJonathan D Schoenfeld, Anand Mahadevan, Scott R Floyd, et al.
Future Oncology (London, England)|January 10, 2024
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study designRobert L Ferris, Hisham Mehanna, Jonathan D Schoenfeld, et al.
Oral Oncology|April 14, 2020
Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinomaGlenn J Hanna, Ji Eun Bae, Jochen H Lorch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 31, 2019
Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United StatesBrandon A Mahal, Paul J Catalano, Robert I Haddad, et al.
Gynecologic Oncology|April 24, 2025
A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancerKelly J Fitzgerald, Panagiotis Konstantinopoulos, Ursula Matulonis, et al.
Pageof 14